MiR-136-5p was found to inhibit cell proliferation, migration and invasion in renal cell carcinoma [34], liver cancer - by regulating IRX5 [35], and in colon cancer, through targeting LRH-1/Wnt signaling [36]. Here, IRX5 is linked to malignant colon neoplasm.